When: Tuesday, December 15, 2:00 p.m.–3:00 p.m. Eastern
Foundation Scientific Council Member
Professor, Departments of Psychiatry, Neuroscience, Genetics and Genomic Sciences
Vice Chair for Research, Department of Psychiatry
Director, Seaver Autism Center for Research and Treatment
Chief, Center of Excellence in Neurodevelopmental Disorders, Friedman Brain Institute
Mount Sinai School of Medicine
Dr. Buxbaum is a molecular neurobiologist at the forefront of research into human psychiatric and neurological diseases. His laboratory focuses on autism, schizophrenia and Alzheimer’s disease using the methods of genetics, gene expression, and protein pathway analysis to identify molecules that contribute to disease. These molecules are studied in cell biological assays and in animal models to understand their function and how they act in disease progression. The findings are ultimately being used to define novel targets for possible therapeutic interventions. The laboratory has published over 180 papers in these areas.
Dr. Buxbaum received his Ph.D. from the Weizmann Institute of Science in Rehovot, Israel and was a Postdoctoral Fellow at Rockefeller University with Dr. Paul Greengard. He holds the G. Harold and Leila Y. Mathers Research Professorship of Geriatrics and Adult Development at the Mount Sinai School of Medicine.
President & CEO
Brain & Behavior Research Foundation
Dr. Jeffrey Borenstein, a board certified psychiatrist, has dedicated his professional life to the mental health field and to improving the lives of those with mental illness. He also serves as Editor-in-Chief of the American Psychiatric Association’s Psychiatric News, Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons and host of the award-winning Public Television series “Healthy Minds,” a program designed to educate people and dispel myths about mental illness.